Brief Summary

This is a case series study evaluating the feasibility and dosage of Intensive Mobility Training (IMT). Twelve participants with chronic, mild-to-moderate, Traumatic Brain Injury (TBI) causing significant locomotor impairment, who meet these specific criteria, will be recruited. Location and nature of neural insult will be determined by multimodal Magnetic Resonance Imaging (MRI) exam. All participants will receive 3 hours of rehabilitation per day for 20 days, focusing on gait and balance. Locomotion and balance will be comprehensively tested prior to IMT, after 10 days of IMT, and then again after the full dose of IMT. This study will determine the feasibility of this intervention in the population of TBI patients, allow an estimate of effect size and provide initial information on possible neural predictors of success. Furthermore the investigators will be able to determine whether the dosage of 10 days is sufficient or whether significant improvements are made with 20 days of the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 16, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 17, 2011

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
Last Updated

April 26, 2013

Status Verified

April 1, 2013

Enrollment Period

1.7 years

First QC Date

August 16, 2011

Last Update Submit

April 25, 2013

Conditions

Keywords

physical therapy techniquesbrain injuries, traumaticwalkinggaitpostural balance

Outcome Measures

Primary Outcomes (3)

  • Feasibility as measured by study completion.

    Feasibility will be determined by the ratio of participants that complete the intervention.

    post-treatment (after 20-day intervention)

  • Feasibility as measured by pain ratings.

    Feasibility will be determined by daily change in pain scores as measured using visual analog scales.

    during 20-day intervention

  • Feasibility as measured by fatigue ratings.

    Feasibility will be determined by daily change in fatigue scores as measured using visual analog scales.

    during 20-day intervention

Secondary Outcomes (1)

  • Efficacy as measured by improvements in gait and mobility.

    from pre- to post-treatment during 20-day intervention.

Study Arms (1)

Intensive Mobility Training (IMT)

EXPERIMENTAL

Intensive Mobility Training will be used as an intensive physical therapy intervention. Participants will receive 3 hours per day for a 10 day session, be post-tested, and receive another 10 day session followed by two more testing sessions.

Behavioral: Intensive Mobility Training (IMT)

Interventions

Intensive Mobility Training will be used as an intensive physical therapy intervention. Participants will receive 3 hours per day for a 10 day session, be post-tested, and receive another 10 day session followed by two more testing sessions.

Intensive Mobility Training (IMT)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • greater than 3 months post-TBI (as defined by INTRuST criteria) and no longer receiving care as an inpatient in a rehabilitation facility.
  • the ability to follow simple three-step commands;
  • the ability to communicate presence and location of pain;
  • the ability to sit independently without back or arm support for five minutes;
  • the ability to stand with support of a straight cane, quad cane, or walker for 2 minutes;
  • the ability to walk 10 meters with maximum 1 person assisting;
  • presence of motor deficits (determined by clinical assessment of paresis);
  • age ≥ 18;
  • ability to give consent or have a acceptable surrogate capable of giving consent on subject's behalf

You may not qualify if:

  • unable to ambulate 500 feet prior to TBI;
  • history of serious chronic obstructive pulmonary disease or oxygen dependence;
  • severe weight bearing pain;
  • lower-extremity amputation;
  • non-healing ulcers on the lower-extremity;
  • renal dialysis or end stage liver disease;
  • legal blindness or severe visual impairment;
  • severe arthritis or orthopedic problems that limit passive ranges of motion of lower extremity (knee flexion contracture of -10°, knee flexion Range of Motion \< 90°, hip flexion contracture \> 25°, and ankle plantar flexion contracture \> 15°);
  • history of deep venous thrombosis or pulmonary embolism within 6 months
  • uncontrollable diabetes with recent weight loss, diabetic coma, or frequent insulin reactions;
  • severe hypertension with systolic greater than 200 mmHg and diastolic greater than 110 mmHg at rest;
  • intracranial hemorrhage related to aneurysm rupture or an arteriovenous malformation (hemorrhagic infarctions will not be excluded);
  • history of severe uncontrolled seizure disorder;
  • other neurological conditions such as multiple sclerosis or Parkinson's Disease;
  • pain that is scored greater than 5 out of 10 on a visual analog scale;
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

921 Assembly Street, 3rd Floor, Public Health Research Center, University of South Carolina

Columbia, South Carolina, 29208, United States

Location

MeSH Terms

Conditions

Mobility LimitationBrain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Stacy Fritz, Ph.D., P.T.

    University of South Carolina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2011

First Posted

August 17, 2011

Study Start

July 1, 2011

Primary Completion

March 1, 2013

Study Completion

March 1, 2013

Last Updated

April 26, 2013

Record last verified: 2013-04

Locations